Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Miller, Rosalind (2020) Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 18 (1). pp. 1-7. ISSN 2405-5794

	Text vol 18 no 1 2020.pdf - Published Version Restricted to Repository staff only Download (5MB)
	Text vol 19 no 1 2020.pdf - Published Version Restricted to Repository staff only Download (13MB)
	Text vol 20 no1 2020.pdf - Published Version Restricted to Repository staff only Download (15MB)
	Text vol 21 no 2020.pdf - Published Version Restricted to Repository staff only Download (18MB)

Abstract

Pharmacies hold great potential to contribute meaningfully to tuberculosis (TB) control efforts, given their accessibility and extensive utilisation by communities in many high burden countries. Despite this promise, the quality of care provided by pharmacies in these settings for a range of conditions has historically been poor. This paper sets out to conceptualise the key issues surrounding quality of TB care in the low- and middle-income country pharmacy setting; examine the empirical evidence on quality of care; and review the interventions employed to improve this. A number of quality challenges are apparent in relation to anti-TB medicine availability,pharmacopeial quality of anti-TB medicines stocked, pharmacy workers’ knowledge, and management of patients both prior to and following diagnosis. Poor management practices include inadequate questioning of symptomatic patients, lack of referral for testing, over-the-counter sale of anti-TB medication as well as unnecessary and harmful medicines (e.g., antibiotics and steroids), and insufficient counselling. Interventions to improve pharmacy practice in relation to TB control have all fallen under the umbrella of public-private mix (PPM) initiatives, where by pharmacies are engaged into national TB programmes to improve case detection. These interventions all involved training of pharmacists to refer symptomatic patients for testing and have enjoyed reasonable success, although achieving scale remains a challenge. Future interventions would do well to expand their focus beyond case detection to also improve counselling of patients and inappropriate medicine sales. The lack of pharmacy-specific global guidelines and the regulatory environment were identified as key areas for future attention.

Item Type:	Article
Subjects:	R Medicine > R Medicine (General)
Depositing User:	Stikes Borneo Cendekia Medika
Date Deposited:	23 Oct 2020 12:38
Last Modified:	02 Nov 2020 03:40
URI:	http://repository.stikesbcm.ac.id/id/eprint/85

Actions (login required)

View Item